To determine whether 1,25(OH)2D3 affected RANKL expression and associated cytokines, we tested three different doses of 1,25(OH)2D3 in anti-CD3/CD28-treated PBMCs of RA patients and healthy volunteers. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.